|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/14 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 3555097 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17854175.1 |
| Date of filing the European patent application | 2017-12-15 | |
| (97) | Date of publication of the European application | 2019-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-15 |
| (46) | Date of publication of the claims translation | 2022-08-25 |
| (86) | Number | PCT/US2017/066744 |
| Date | 2017-12-15 |
| (87) | Number | WO 2018/112379 |
| Date | 2018-06-21 |
| (30) | Number | Date | Country code |
| 201662435609 P | 2016-12-16 | US | |
| 201762592680 P | 2017-11-30 | US | |
| 201762596607 P | 2017-12-08 | US |
| (72) |
KOUDRIAKOVA, Tatiana , US
KREUTTER, Kevin D. , US
LEONARD, Kristi , US
RIZZOLIO, Michele C. , US
SMITH, Russell C. , US
TICHENOR, Mark S. , US
WANG, Aihua , US
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip Janus kinazės inhibitoriai |
| IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDINE COMPOUNDS AS INHIBITORS OF JANUS KINASES |
| Payment date | Validity (years) | Amount | |
| 2025-11-03 | 9 | 208.00 EUR |
| 2026-12-15 |